Shanghai Pharmaceuticals: Tobramycin Sulfate Injection Passes Consistency Evaluation of Generic Drugs

Shanghai Pharmaceuticals Announcement: Recently, the subsidiary Shanghai Hefeng Pharmaceutical Co., Ltd.'s Tobramycin Sulfate Injection received the “Notification of Approval for Supplementary Application of Drugs” (Notification No.: 2026B01918) issued by the National Medical Products Administration. The drug has passed the consistency evaluation of generic drugs.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin